CRO市场分析.ppt

  1. 1、本文档共13页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
CRO市场分析

竞争分析 国内药物研发服务型公司的竞争是高度分散的 国内竞争对手服务类型分析 公司名称 Chemistry Biology Scale up mfg. Preclinical Clinical Clinical central lab 保诺科技(BioDuro)NowPPD √ √ 开拓者 (Charles River) √ Bridge lab √ 凯美隆(Chemizon) √ 睿智(ChemPartner) √ √ √ Covance √ 中美冠科(Crown Biosciences) √ Frontier Bioscience √ 吉尔生化(GL Biochem) √ 辉源(HD Biosciences) √ 北京美迪生(MDS Pharma Service) √ √ 上海美迪西Medicilon (JV) √ √ √ 国家上海新药安全评价研究中心 √ 金斯特(GenScript) √ 澎立生物(PharmaLegacy) √ 药明康德(Wu Xi PharmaTech) √ √ √ √ PPDI(Pharmaceutical Product Development, Inc ) √ 兴德通(Sinocro) √ √ √ 肇庆创药(SNBL) √ 桑地亚(Sundia) √ √ (1) Source: Investment bank research report. 公司差异化、核心竞争力及比较竞争优势 蛋白结晶技术 化合物浸泡和共结晶 蛋白类药物同位素测试 筛选建模 (cancer) 筛选建模 (CNS) 综合 services (Product) 中国市场 Medicilon ++++ ++++ ++++ ++++ ++++ ++++ ++++ Wuxi + + ++ (USA) +++ +++ +++ + Shangpharm + + ++ ++ ++ + CrownBio +++++ + ++ Pharmaron + + +++ + PPD ++ +++ Sundia + + +++ + VivaBiotech ++ ++ Genscript + + + Medicilon: Public Attention Outsourcing in Drug Discovery, 2nd Edition 2006 As one of top 30 international drug discovery CRO companies As one of top 3 Chinese drug discovery CRO companies (Medicilon, Bridge and Wuxi were featured) Globalization of Drug Development: China (A CHA report) 2006 As one of top 5 CRO companies in China Wall Street Reporter Telephone Interview (Sept. 18, 2006) Chemical Engineering News, SPRUNG FROM MEDICHEM Dec. 20, 2004 Chemical Engineering News, CHINESE INDUSTRIAL PARKS UP THE ANTE, Oct. 31, 2006 Business D - “Shanghai High-Tech Future” Nov. 27, 2006 Chemical Engineering News, CHINA STRIDES TOWARD GLOBAL PHARMA ROLE, March 12, 2007 Chemical Engineering News, MEDICILON STRIVES TO KEEP THE PACE, JUNE 9, 2008 Pharmaceutical Executive, Media Center Interviews, Dec, 2009. Advantage to Work in Medicilon US FDA GLP compliance toxicology services Shanghai government authorized platforms for both non-human primate studies and structural biology Have passed audit by sFDA for more than 10 times Have served over 150 companies around the world Fi

文档评论(0)

kuailexingkong + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档